You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tobramycin, Dexamethasone Drug Combination

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fractures, Open, Wounds and Injuries--Infections, Anti-Bacterial Agents Trial in Aurora, Denver (Vancomycin, Tobramycin)

Active, not recruiting
  • Fractures, Open
  • +5 more
  • Aurora, Colorado
  • +1 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
  • Atlanta, Georgia
  • +25 more
Aug 31, 2022

Kyprolis® in Combination With Revlimid® and Dexamethasone or

Recruiting
  • Multiple Myeloma in Relapse
  • Frankfurt, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Jun 2, 2022

Multiple Myeloma Trial in Canada, United States (PF-06863135 monotherapy IV or SC, PF-06863135 + dexamethasone, PF-06863135 +

Active, not recruiting
  • Multiple Myeloma
  • PF-06863135 monotherapy IV or SC
  • +3 more
  • Encinitas, California
  • +37 more
Jul 7, 2022

Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Eftozanermin alfa
  • +2 more
  • Atlanta, Georgia
  • +18 more
Oct 12, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +8 more
Jan 12, 2023

Comparison of Efficacy of Sclerotherapy in Infantile Hemangioma Trial in Lahore (Comparison of intralesional injection of

Completed
  • Comparison of Efficacy of Sclerotherapy in Infantile Hemangioma
  • Comparison of intralesional injection of bleomycin alone and combined with injection dexamethasone
  • Lahore, Punjab, Pakistan
    department of pediatric surgery King Edward Medical University
Oct 6, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Carfilzomib, Cyclophosphamide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Jun 8, 2023

Multiple Myeloma Trial in Toulouse (Carfilzomib/Lenalidomide/Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Toulouse, France
  • +1 more
Jul 29, 2020

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 1, 2022

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma Trial in United States (drug,

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Anchorage, Alaska
  • +459 more
Dec 7, 2022

Multiple Myeloma, Cancer Trial in Chapel Hill, Durham, Columbus (Isatuximab, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Cancer
  • Chapel Hill, North Carolina
  • +2 more
Jun 30, 2022

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Multiple Myeloma Trial in Seoul (Carfilzomib 56 MG [Kyprolis], Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Carfilzomib 56 MG [Kyprolis]
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 19, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Jan 9, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Fountain Valley, California
  • +107 more
Dec 7, 2022

Cystic Fibrosis Trial in France (Tobi Inhalant Product, Nebcin)

Terminated
  • Cystic Fibrosis
  • Amiens, France
  • +6 more
Aug 30, 2021

Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • High Risk Smoldering Multiple Myeloma
  • Basking Ridge, New Jersey
  • +5 more
Nov 15, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • ISS Stage III Plasma Cell Myeloma
  • Plasma Cell Myeloma
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

Withdrawn
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Elotuzumab, Selinexor, and Dexamethasone (ESd)
  • (no location specified)
Apr 27, 2022

Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

Recruiting
  • Recurrent AL Amyloidosis
  • Refractory AL Amyloidosis
  • Biospecimen Collection
  • +9 more
  • Duarte, California
  • +10 more
Jan 19, 2023

Plasma Cell Myeloma Trial in Worldwide (Isatuximab SAR650984, Bortezomib, Lenalidomide)

Active, not recruiting
  • Plasma Cell Myeloma
  • Isatuximab SAR650984
  • +3 more
  • Fort Myers, Florida
  • +103 more
Nov 3, 2022

Multiple Myeloma Trial in Charlotte (Elotuzumab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 24, 2023